In Vitro Activity of ABT-773, a New Ketolide, against Recent Clinical Isolates of Streptococcus pneumoniae , Haemophilus influenzae , and Moraxella catarrhalis
Open Access
- 1 February 2000
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 44 (2) , 447-449
- https://doi.org/10.1128/aac.44.2.447-449.2000
Abstract
The in vitro activity of ABT-773 was evaluated against Streptococcus pneumoniae , Haemophilus influenzae , and Moraxella catarrhalis isolates. ABT-773 was the most active antimicrobial tested against S. pneumoniae . ABT-773 and azithromycin were equivalent in activity against H. influenzae and M. catarrhalis and more active than either clarithromycin or erythromycin.Keywords
This publication has 4 references indexed in Scilit:
- Antimicrobial Resistance with Streptococcus pneumoniae in the United States, 1997–98Emerging Infectious Diseases, 1999
- A 1997–1998 national surveillance study: Moraxella catarrhalis and Haemophilus influenzae antimicrobial resistance in 34 US institutionsInternational Journal of Antimicrobial Agents, 1999
- Prevalence and Characterization of the Mechanisms of Macrolide, Lincosamide, and Streptogramin Resistance in Isolates of Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 1998
- Novel mechanism of macrolide resistance in Streptococcus pneumoniaeDiagnostic Microbiology and Infectious Disease, 1996